Aclaris Therapeutics Inc ACRS

‎$‎1.76-0.15(-7.85%)(1D)

• Delayed prices by Nasdaq • in USD

Invest in Aclaris Therapeutics Inc
Today

Create an eToro account to buy ACRS stock on a secure, user-friendly, multi-asset trading platform.

Aclaris Therapeutics Inc ACRS

Buy ACRS

Analyst Forecast

Consensus

Moderate Buy

Price Target

11.50

Based on analysts who covered ACRS

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Nuernberger Beteiligungs AG

Papa John's International Inc

More about Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is involved in identifying, developing and commercialising novel, small molecule therapies for people with dermatological and immunological diseases.

Operational in the biotechnology industry, Aclaris Therapeutics Inc focuses on providing solutions to multiple dermatological and immunological conditions through KINect, its drug discovery technology platform. The company’s product pipeline aims to target conditions such as rheumatoid arthritis, inflammatory bowel disease and pancreatic cancer. Aclaris Therapeutics Inc operates Confluence Discovery Technologies Inc as an indirect, wholly owned subsidiary.

Add ACRS stock to your eToro virtual portfolio.

ACRS Stock Price Chart

‎-4.89‎

Past Month

MAX

*Past performance is not an indication of future results

The Aclaris Therapeutics Inc share price is on the decline this week.

The Aclaris Therapeutics Inc price today is ‎$‎1.76, a ‎-7.85‎% change in the last 24 hours and ‎-3.85‎% in the past week. Aclaris Therapeutics Inc price changed by ‎54.87‎% in the past year.

Jump to:

About ACRS >
How to Buy? >
Top Guides >

ACRS Key Metrics

Market Cap

Day’s Range

‎$‎1.72 - ‎$‎1.86

52W Range

‎$‎0.9301 - ‎$‎5.12

Average Volume (3M)

Price-Earnings Ratio

Revenue

Dividend (Yield)

Prev Close

‎$‎1.91

EPS

Beta

What Is Aclaris Therapeutics Inc?

Get Started

How can I buy Aclaris Therapeutics Inc stocks?

To purchase Aclaris Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Aclaris Therapeutics Inc (ACRS) page and place an order to buy Aclaris Therapeutics Inc.

Buy ACRS

Looking for more information? Check out our guide on Academy.

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2025

Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.

Stock Trading And Investing For Beginners

New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.

AI Stocks Poised for Growth in 2025

Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Aclaris Therapeutics Inc
Today

Create an eToro account to buy ACRS stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Aclaris Therapeutics Inc stock?

The current price of ACRS is ‎$‎1.76.

What is Aclaris Therapeutics Inc’s stock future price target?

The average price target for Aclaris Therapeutics Inc is ‎$‎11.50. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Aclaris Therapeutics Inc?

Analysts offer forecasts for Aclaris Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Aclaris Therapeutics Inc?

The market capitalisation of Aclaris Therapeutics Inc is -

Is Aclaris Therapeutics Inc stock buy, sell or hold?

Based on 2 analysts offering recommendations for ACRS in the last 3 months, the overall consensus is Moderate Buy.

Daily Movers

Explore the biggest stocks movers on the market.